Where is Equiplex located?

Equiplex is headquartered in Goias, Brazil.

How many employees does Equiplex have?

As of Apr 30, 2026, the latest employee count at Equiplex is 503.

Is Equiplex a funded company?

Equiplex is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Equiplex rank among its competitors?

Equiplex ranks 14th amongst 285 active competitors, of which 21 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Kardigan, which secured $254M in Oct, 2025.

Who are the top competitors of Equiplex?

Equiplex's top competitors include Aragen, OneSource and Kardigan. Among them, Kardigan secured the most recent funding round in October, 2025.

Equiplex - 2026 Company Profile & Competitors

Company Details

Manufacturer of high-quality pharmaceutical medications. It produces a variety of medications, focusing on small and large-volume production. The company utilizes advanced technology in its manufacturing processes and maintains rigorous quality and safety controls. Its products are distributed internationally.

Website: equiplex.com.br
Social

Key Metrics

Founded Year

1986

Location

Goias, Brazil

Stage

Unfunded

Ranked

14^th among 285 active competitors

Employee Count

503 as on Apr 30, 2026

Similar Companies

Aragen & 289 more

View Equiplex's full profile

Equiplex has not raised any funding rounds yet.

Equiplex's employee count trend

Equiplex has 503 employees as of Apr 26. Here is Equiplex's employee count trend over the years:

Uncover Equiplex's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Equiplex include Aragen, OneSource and Kardigan. Here is the list of Top 10 competitors of Equiplex, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Aragen 2001, Hyderabad (India), Series B	Provider of drug discovery, clinical development, manufacturing, and other services for small molecules	$161M	Goldman Sachs, Quadria Capital & 18 others	69/100
2nd	OneSource 1990, Bengaluru (India), Public	Pharmaceutical contract development and manufacturing organization offering pharmaceutical products	$155M	Erasmic Venture Fund, Accel & 14 others	65/100
3rd	Kardigan 2023, San Francisco (United States), Series B	Biotech company developing personalized medicines for cardiovascular diseases	$554M	Perceptive Advisors, Sequoia Heritage & 3 others	57/100
4th	Vectura 1997, Chippenham (United Kingdom), Acquired	Developer of inhaled therapeutics for respiratory diseases	$15.2M	HBM Healthcare Investments, EQT & 5 others	57/100
5th	Suanfarma 1993, Madrid (Spain), Acquired	Developer of generics, nutraceuticals, and APIs	-	Hermes GPE	56/100
6th	revalia bio 2021, New Haven (United States), Seed	Provider of contract based drugs development services for biopharma sector	$26.8M	Sierra Ventures, AFF & 4 others	53/100
7th	Wheeler Bio 2020, Oklahoma City (United States), Series A	Provider of drug research and analytical development services for multiple therapeutic areas	$103M	Echo, Charles River Laboratories & 13 others	52/100
8th	Nephron Pharmaceuticals 1937, Florida (Puerto Rico), Late Stage	Manufacturer of sterile pharmaceutical products and provider of contract manufacturing and 503B outsourcing services	$625M	Blackrockbkcc, PNC & 3 others	51/100
9th	Quotient Sciences 1990, Nottingham (United Kingdom), Acquired	Developer and manufacturer of APIs as well as finished dosage forms	-	GHO Capital Partners	47/100
10th	LSL Pharma Group 2023, Boucherville (Canada), Public	Integrated pharmaceutical company provides pharma products	-	-	47/100
14th	Equiplex 1986, Goias (Brazil), Unfunded	Manufacturer of high-quality pharmaceutical medications	-	-	41/100